|
⚲
|
| Keyboard |
| Artal International Management SA
✚
|
|
|---|---|
| CIK # | 0001522131 |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| CAVA Group Inc | 0.8 | ||
| Lexicon Pharmaceuticals Inc/DE | 0.2 | ||
| Holdings by Sector ($B) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-NT | [0001522131] | |
| 3 | [0001522131] | |
| 4 | [0001522131] | |
| SC 13G | [0001522131] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Artal International Management Sa | Rubius Therapeutics Inc | [2021-03-08] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lexicon Pharmaceuticals Inc LXRX
Series B Convertible Preferred Stock
|
2026-02-17 | Grant | 41,289.58 | $65.00 | 2,683,823 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2026-02-02 | Grant | 18,553,846 | $1.30 | 24,120,000 |
|
Lexicon Pharmaceuticals Inc LXRX
Series B Convertible Preferred Stock
|
2026-02-02 | Grant | 367,145.12 | $65.00 | 23,864,433 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2026-02-02 | Buy | 1,538,462 | $1.30 | 2,000,001 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2026-02-02 | Grant | 3,846,154 | $1.30 | 5,000,000 |
|
CAVA Group Inc CAVA
Common Stock
|
2024-11-18 | Sell | 8,000,000 | $134.13 | 1,073,040,000 |
|
CAVA Group Inc CAVA
Common Stock
|
2024-08-26 | Sell | 6,000,000 | $116.36 | 698,160,000 |
|
CAVA Group Inc CAVA
Common Stock
|
2024-06-05 | Sell | 3,000,000 | $87.25 | 261,750,000 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2024-05-10 | Option exercise | 57,546,100 | ||
|
Lexicon Pharmaceuticals Inc LXRX
Series A Convertible Preferred Stock · derivative
|
2024-05-10 | Option exercise | 1,150,922 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Series A Convertible Preferred Stock · derivative
|
2024-05-10 | Grant | 1,150,922 | $108.50 | 124,875,037 |
|
CAVA Group Inc CAVA
Common Stock
|
2024-03-21 | Sell | 2,000,000 | $66.25 | 132,500,000 |
|
Lexicon Pharmaceuticals Inc LXRX
Series A Convertible Preferred Stock
|
2024-03-13 | Grant | 1,150,922 | $108.50 | 124,875,037 |
|
CAVA Group Inc CAVA
Common Stock
|
2024-02-27 | Sell | 3,500,000 | $53.60 | 187,600,000 |
|
Scholar Rock Holding Corp SRRK
Common Stock
|
2023-10-12 | Buy | 2,189,781 | $6.85 | 15,000,000 |
|
Scholar Rock Holding Corp SRRK
Common Stock
|
2023-10-12 | Buy | 10,150 | $8.55 | 86,782 |
|
CAVA Group Inc CAVA
Common Stock
|
2023-06-20 | Option exercise | 1,993,092 | ||
|
CAVA Group Inc CAVA
Common Stock
|
2023-06-20 | Option exercise | 22,252,464 | ||
|
CAVA Group Inc CAVA
Common Stock
|
2023-06-20 | Option exercise | 1,568,865 | ||
|
CAVA Group Inc CAVA
Common Stock
|
2023-06-20 | Option exercise | 3,486,366 | ||
| showing 20 of 117 most recent transactions | |||||